Suchergebnisse - "Jin, Jiaoyue"

PubPharm (25)

1

Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma

enthalten in: iScience | 2023

von Ying, L. | Zhang, C. | Reuben, A. | +15

2

PDZ-binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway

enthalten in: Molecular carcinogenesis | 2023

von Feng, T. | Jiang, R. | Yin, L. | +12

3

PDZ‐binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway

enthalten in: Molecular Carcinogenesis | 2023

von Feng, T. | Jiang, R. | Yin, L. | +12

4

Tumor-infiltrating lymphocytes-based subtypes and genomic characteristics of EBV-associated lymphoepithelioma-like carcinoma

enthalten in: The Journal of pathology | 2022

von Yin, W. | Jin, J. | Bao, H. | +10

5

FGF19 amplification as biomarker for predicting sensitivity of FGFR inhibitor in esophageal squamous cell carcinoma and potential application of biomarker

enthalten in: Europäisches Patentamt | 2022

von SU DAN | YING LISHA | JIN JIAOYUE | +3

6

Biodegradable iron oxide nanoparticles for intraoperative parathyroid gland imaging in thyroidectomy

enthalten in: PNAS nexus | 2022

von Zheng, W. | Liu, C. | Jin, J. | +11

ErratumIn: PNAS Nexus. 2024 Jan 30;3(1):pgad462. - PMID 38292557

7

Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma

enthalten in: Cancers | 2022

von Tian, Y. | Lai, Q. | Zheng, Y. | +8

8

Tumor‐infiltrating lymphocytes‐based subtypes and genomic characteristics of EBV‐associated lymphoepithelioma‐like carcinoma

enthalten in: The Journal of Pathology | 2022

von Yin, W. | Jin, J. | Bao, H. | +10

9

Development of a serum miRNA panel for detection of early stage non-small cell lung cancer

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2020

von Ying, L. | Du, L. | Zou, R. | +24

10

Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma

enthalten in: Annals of translational medicine | 2020

von Huang, M. | Jin, J. | Zhang, F. | +4